|
The
following table sets forth total non-cash share-based compensation for the issuance of common stock, options to purchase common stock,
warrants to purchase common stock, and restricted stock unit awards by operating statement classification for the three and nine months
ended September 30, 2023 and 2022:
Schedule
of Stock-based Compensation
| |
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|
| |
|
Three Months ended September 30,
|
|
|
Nine Months ended September 30,
|
|
| |
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|
| Research and development |
|
$ |
27 |
|
|
$ |
96 |
|
|
$ |
107 |
|
|
$ |
292 |
|
| Sales and marketing |
|
|
5 |
|
|
|
60 |
|
|
|
6 |
|
|
|
184 |
|
| General and administrative |
|
|
61 |
|
|
|
285 |
|
|
|
251 |
|
|
|
947 |
|
| Total |
|
$ |
93 |
|
|
$ |
441 |
|
|
$ |
364 |
|
|
$ |
1,423 |
|
|